Shenzhen Dynanonic Co., Ltd (SHE:300769)
66.50
+3.37 (5.34%)
Jun 30, 2026, 3:04 PM CST
Shenzhen Dynanonic Revenue
Shenzhen Dynanonic had revenue of 4.34B CNY in the quarter ending March 31, 2026, with 116.43% growth. This brings the company's revenue in the last twelve months to 11.05B, up 43.04% year-over-year. In the year 2025, Shenzhen Dynanonic had annual revenue of 8.72B with 14.50% growth.
Revenue (ttm)
11.05B
Revenue Growth
+43.04%
P/S Ratio
1.58
Revenue / Employee
2.90M
Employees
3,812
Market Cap
17.51B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8.72B | 1.10B | 14.50% |
| Dec 31, 2024 | 7.61B | -9.36B | -55.15% |
| Dec 31, 2023 | 16.97B | -5.58B | -24.76% |
| Jan 1, 2023 | 22.56B | 17.60B | 355.30% |
| Jan 1, 2022 | 4.95B | 4.01B | 425.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Guizhou Chanhen Chemical | 8.66B |
| Tinergy Chemical | 7.93B |
| Sichuan Hebang Biotechnology Corporation | 6.85B |
| Valiant Co.,Ltd | 3.87B |
| Tayho Advanced Materials Group | 3.59B |
| Sichuan Xinjinlu Group | 1.67B |
| Guangdong Orient Zirconic Ind Sci & Tech Co.,Ltd | 1.26B |
| Hunan Boyun New Materials Co.,Ltd | 1.12B |
Shenzhen Dynanonic News
- 2 months ago - Shenzhen Dynanonic Annual report: H2 2025 - Filings
- 2 months ago - Shenzhen Dynanonic Quarterly report: Q1 2026 - Filings
- 8 months ago - Shenzhen Dynanonic Quarterly report: Q3 2025 - Filings
- 10 months ago - Shenzhen Dynanonic Quarterly report: H1 2025 - Filings